ANGPT2 and hepatocellular carcinoma: A prior study has shown (31) that a prepared single-chain variable fragment (scFv) Ang-2 single-chain antibody has a significant inhibitory effects on the angiogenesis and tumor growth of HCC in vivo and in vitro.